P-ISSN 0854-4425  | E-ISSN 2338-834X |  DOI 10.47349/jbi
  Open Access   Peer Reviewed
Share this article to:
  English

Volume 22 Number 1 Year 2026
Pages 103 - 112

Molecular Docking Insights into CCL5-CCR5 and Maraviroc-CCR5 Interactions: Structural Basis for Chemokine Receptor Antagonism

Analisis Docking Molekuler terhadap Interaksi CCL5-CCR5 dan Maraviroc-CCR5: Dasar Struktural untuk Antagonisme Reseptor Kemokin

Author:
  1. Jefferson Hosea Setiabang
  2. Jessica Ashley Hartono
  3. Jessie Maria Tanamas
  4. Justin Chang
  5. Arli Aditya Parikesit
Abstract:

COVID-19 infection has been associated with increased risk of cardiovascular complications, including heart failure. The chemokine CCL5 (RANTES) and its primary receptor, CCR5, play critical roles in immune cell recruitment and inflammatory responses in cardiac tissues. Maraviroc, an approved CCR5 antagonist, has demonstrated potential in reducing cardiovascular complications in HIV-infected patients, warranting investigation of its applicability in COVID-19-related heart failure.  This study set out to map the binding interactions of maraviroc at the CCR5 active site and the structural interface of the CCL5–CCR5 complex through molecular docking, to assess whether maraviroc holds computational merit as a candidate for blocking CCL5-mediated cardiac inflammation in COVID-19 patients. Molecular docking was performed to evaluate the binding interactions of (1) maraviroc to CCR5 using AutoDock Vina 1.2.7, and (2) CCL5 to CCR5 using the HDOCK web server. Three-dimensional structures of CCR5 and CCL5 were retrieved from the Protein Data Bank (PDB), while maraviroc’s structure was obtained from PubChem. PyMOL was used to visualise docking results. Maraviroc showed strong binding affinity to CCR5 with a docking score of −10.8 kcal/mol (best mode) and acceptable RMSD values of 0.844 Å (lower bound) and 2.111 Å (upper bound) in Mode 3. CCL5 docking to CCR5 via HDOCK yielded a high docking score of −345.56 with a confidence score of 0.9804, though ligand RMSD values were large, suggesting positional deviations from the native pose: Maraviroc demonstrated favourable binding affinity for CCR5, supporting its potential to block CCL5-mediated inflammatory signalling implicated in COVID-19-associated heart failure. Further optimisation of docking protocols and molecular dynamics simulations is recommended to validate these findings.

 

Kata Kunci:
Keywords:
© 2020  Perhimpunan Biologi Indonesia
Install App